Andreas is an Associate Professor at the Technical University of Denmark, where he heads the Tropical Pharmacology Lab. This academic group specializes in antibody technologies and synthetic biology with a particular focus on developing therapies and diagnostics against neglected tropical diseases. This includes snakebite envenoming, and infectious diseases. Besides his academic work, Andreas is a co-founder of the companies Biosyntia ApS, Antag Therapeutics ApS, Chromologics ApS, and VenomAid Diagnostics ApS. He has been an advisor for the World Health Organization and is a leading expert on the application of antibody technologies for neglected tropical diseases. Andreas is a Fellow of the Young Academy of Europe and the Young Academy of Denmark.
Andreas supports Bactolife™’s R&D strategy and activities and serves as Chairman of the Scientific Advisory Board.